240 related articles for article (PubMed ID: 12810613)
1. Overexpression of the serotonin 5-HT2B receptor in heart leads to abnormal mitochondrial function and cardiac hypertrophy.
Nebigil CG; Jaffré F; Messaddeq N; Hickel P; Monassier L; Launay JM; Maroteaux L
Circulation; 2003 Jul; 107(25):3223-9. PubMed ID: 12810613
[TBL] [Abstract][Full Text] [Related]
2. Serotonin is a novel survival factor of cardiomyocytes: mitochondria as a target of 5-HT2B receptor signaling.
Nebigil CG; Etienne N; Messaddeq N; Maroteaux L
FASEB J; 2003 Jul; 17(10):1373-5. PubMed ID: 12738797
[TBL] [Abstract][Full Text] [Related]
3. Ablation of serotonin 5-HT(2B) receptors in mice leads to abnormal cardiac structure and function.
Nebigil CG; Hickel P; Messaddeq N; Vonesch JL; Douchet MP; Monassier L; György K; Matz R; Andriantsitohaina R; Manivet P; Launay JM; Maroteaux L
Circulation; 2001 Jun; 103(24):2973-9. PubMed ID: 11413089
[TBL] [Abstract][Full Text] [Related]
4. Cardiac-specific overexpression of diacylglycerol kinase zeta prevents Gq protein-coupled receptor agonist-induced cardiac hypertrophy in transgenic mice.
Arimoto T; Takeishi Y; Takahashi H; Shishido T; Niizeki T; Koyama Y; Shiga R; Nozaki N; Nakajima O; Nishimaru K; Abe J; Endoh M; Walsh RA; Goto K; Kubota I
Circulation; 2006 Jan; 113(1):60-6. PubMed ID: 16380548
[TBL] [Abstract][Full Text] [Related]
5. Low- and high-level transgenic expression of beta2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galphaq-overexpressing mice.
Dorn GW; Tepe NM; Lorenz JN; Koch WJ; Liggett SB
Proc Natl Acad Sci U S A; 1999 May; 96(11):6400-5. PubMed ID: 10339599
[TBL] [Abstract][Full Text] [Related]
6. Gq-coupled receptor agonists mediate cardiac hypertrophy via the vasculature.
Keys JR; Greene EA; Koch WJ; Eckhart AD
Hypertension; 2002 Nov; 40(5):660-6. PubMed ID: 12411459
[TBL] [Abstract][Full Text] [Related]
7. Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy.
Pontén A; Li X; Thorén P; Aase K; Sjöblom T; Ostman A; Eriksson U
Am J Pathol; 2003 Aug; 163(2):673-82. PubMed ID: 12875986
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation: control of interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha cytokine production by ventricular fibroblasts.
Jaffré F; Callebert J; Sarre A; Etienne N; Nebigil CG; Launay JM; Maroteaux L; Monassier L
Circulation; 2004 Aug; 110(8):969-74. PubMed ID: 15302781
[TBL] [Abstract][Full Text] [Related]
9. Transgenic myocardial overexpression of prokineticin receptor-2 (GPR73b) induces hypertrophy and capillary vessel leakage.
Urayama K; Dedeoglu DB; Guilini C; Frantz S; Ertl G; Messaddeq N; Nebigil CG
Cardiovasc Res; 2009 Jan; 81(1):28-37. PubMed ID: 18806277
[TBL] [Abstract][Full Text] [Related]
10. Cardiac-specific PID1 overexpression enhances pressure overload-induced cardiac hypertrophy in mice.
Liu Y; Shen Y; Zhu J; Liu M; Li X; Chen Y; Kong X; Song G; Qian L
Cell Physiol Biochem; 2015; 35(5):1975-85. PubMed ID: 25871431
[TBL] [Abstract][Full Text] [Related]
11. Functional consequence of serotonin/5-HT2B receptor signaling in heart: role of mitochondria in transition between hypertrophy and heart failure?
Nebigil CG; Maroteaux L
Circulation; 2003 Aug; 108(7):902-8. PubMed ID: 12925446
[No Abstract] [Full Text] [Related]
12. HSP75 protects against cardiac hypertrophy and fibrosis.
Zhang Y; Jiang DS; Yan L; Cheng KJ; Bian ZY; Lin GS
J Cell Biochem; 2011 Jul; 112(7):1787-94. PubMed ID: 21381076
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial complex II participates in normoxic and hypoxic regulation of α-keto acids in the murine heart.
Mühling J; Tiefenbach M; López-Barneo J; Piruat JI; García-Flores P; Pfeil U; Gries B; Mühlfeld C; Weigand MA; Kummer W; Weissmann N; Paddenberg R
J Mol Cell Cardiol; 2010 Dec; 49(6):950-61. PubMed ID: 20920510
[TBL] [Abstract][Full Text] [Related]
14. Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure.
Ohtani T; Mano T; Hikoso S; Sakata Y; Nishio M; Takeda Y; Otsu K; Miwa T; Masuyama T; Hori M; Yamamoto K
J Hypertens; 2009 May; 27(5):1074-83. PubMed ID: 19349910
[TBL] [Abstract][Full Text] [Related]
15. Decompensation of pressure-overload hypertrophy in G alpha q-overexpressing mice.
Sakata Y; Hoit BD; Liggett SB; Walsh RA; Dorn GW
Circulation; 1998 Apr; 97(15):1488-95. PubMed ID: 9576430
[TBL] [Abstract][Full Text] [Related]
16. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations that inhibit in vivo pressure-overload hypertrophy prevent cardiac dysfunction despite increased wall stress.
Esposito G; Rapacciuolo A; Naga Prasad SV; Takaoka H; Thomas SA; Koch WJ; Rockman HA
Circulation; 2002 Jan; 105(1):85-92. PubMed ID: 11772881
[TBL] [Abstract][Full Text] [Related]
18. ROCK1 plays an essential role in the transition from cardiac hypertrophy to failure in mice.
Shi J; Zhang YW; Yang Y; Zhang L; Wei L
J Mol Cell Cardiol; 2010 Nov; 49(5):819-28. PubMed ID: 20709073
[TBL] [Abstract][Full Text] [Related]
19. Cardiomyocyte Hypertrophy in Arrhythmogenic Cardiomyopathy.
Gerçek M; Gerçek M; Kant S; Simsekyilmaz S; Kassner A; Milting H; Liehn EA; Leube RE; Krusche CA
Am J Pathol; 2017 Apr; 187(4):752-766. PubMed ID: 28183531
[TBL] [Abstract][Full Text] [Related]
20. Serotonin 2B receptor is required for heart development.
Nebigil CG; Choi DS; Dierich A; Hickel P; Le Meur M; Messaddeq N; Launay JM; Maroteaux L
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9508-13. PubMed ID: 10944220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
